Shell Asset Management CO Haemonetics Corp Transaction History

Shell Asset Management CO

$2.9 Billion
Q2 2025

A detailed history of Shell Asset Management CO transactions in Haemonetics Corp stock. As of the latest transaction made, Shell Asset Management CO holds 2,146 shares of HAE stock, worth $161,379. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,146

Previous 2,679 19.9%

Holding current value

$161,379

Previous $170,000 5.88%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$56.04 - $74.77 $29,869 - $39,852	-533 Reduced 19.9%	2,146 $160,000
Q1 2025 May 14, 2025	SELL	$59.34 - $80.05 $6,883 - $9,285	-116 Reduced 4.15%	2,679 $170,000
Q3 2024 Nov 07, 2024	SELL	$72.45 - $91.58 $11,664 - $14,744	-161 Reduced 5.45%	2,795 $225,000
Q1 2024 Jul 31, 2024	SELL	$71.24 - $85.35 $13,606 - $16,301	-191 Reduced 6.07%	2,956 $245,000
Q1 2024 May 14, 2024	SELL	$71.24 - $85.35 $7,622 - $9,132	-107 Reduced 3.29%	3,147 $269,000
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $78,897 - $90,665	-979 Reduced 23.13%	3,254 $278,000
Q3 2023 Nov 08, 2023	SELL	$82.56 - $93.49 $5,531 - $6,263	-67 Reduced 1.56%	4,233 $379,000
Q2 2023 Jul 28, 2023	SELL	$80.84 - $89.45 $2,021 - $2,236	-25 Reduced 0.58%	4,300 $366,000
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $1,091 - $1,359	-15 Reduced 0.35%	4,325 $358,000
Q4 2022 Feb 07, 2023	SELL	$73.85 - $86.14 $70,305 - $82,005	-952 Reduced 17.99%	4,340 $341,000
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $87,100 - $108,236	-1,376 Reduced 20.64%	5,292 $392,000
Q2 2022 Aug 09, 2022	BUY	$49.27 - $66.08 $886 - $1,189	18 Added 0.27%	6,668 $435,000
Q1 2022 May 04, 2022	SELL	$43.77 - $63.22 $42,807 - $61,829	-978 Reduced 12.82%	6,650 $420,000
Q4 2021 Feb 09, 2022	BUY	$49.55 - $74.59 $991 - $1,491	20 Added 0.26%	7,628 $405,000
Q3 2021 Nov 04, 2021	SELL	$57.6 - $70.59 $19,008 - $23,294	-330 Reduced 4.16%	7,608 $537,000
Q2 2021 Aug 12, 2021	BUY	$51.81 - $118.56 $22,278 - $50,980	430 Added 5.73%	7,938 $529,000
Q1 2021 May 10, 2021	SELL	$111.01 - $139.48 $5,550 - $6,973	-50 Reduced 0.66%	7,508 $833,000
Q2 2020 Aug 10, 2020	SELL	$84.96 - $118.91 $5,692 - $7,966	-67 Reduced 0.88%	7,558 $677,000
Q1 2020 May 11, 2020	SELL	$74.34 - $121.82 $8,623 - $14,131	-116 Reduced 1.5%	7,625 $760,000
Q4 2019 Feb 13, 2020	SELL	$114.37 - $129.46 $17,727 - $20,066	-155 Reduced 1.96%	7,741 $889,000
Q3 2019 Nov 12, 2019	SELL	$117.16 - $138.52 $7,966 - $9,419	-68 Reduced 0.85%	7,896 $996,000
Q2 2019 Aug 12, 2019	SELL	$81.74 - $120.34 $14,876 - $21,901	-182 Reduced 2.23%	7,964 $958,000
Q4 2018 Feb 13, 2019	SELL	$90.66 - $116.63 $63,462 - $81,641	-700 Reduced 7.91%	8,146 $815,000
Q3 2018 Nov 13, 2018	BUY	$89.96 - $114.58 $795,786 - $1.01 Million	8,846 New	8,846 $1.01 Million

Others Institutions Holding HAE

# of Institutions

352

Shares Held

53.2M

Call Options Held

417K

Put Options Held

314K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.86B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Haemonetics Corp Transaction History